SAN RAFAEL, Calif., Jan. 26, 2026 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) (“BioMarin”) announced today that it intends to…
Read More
Under the agreement, Pulsenmore and Clalit will establish an end-to-end clinical service operated through Beilinson NEXT, Beilinson Medical Center’s virtual…
Read More
NIJMEGEN, The Netherlands, Jan. 26, 2026 /PRNewswire/ — Mair Therapeutics, a Dutch biotechnology company pioneering lysosomal-targeted therapies for neurodegenerative diseases,…
Read More
SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ — Divamics (DIVAMICS), an AI-driven biotechnology company specializing in high-precision molecular discovery, highlighted the…
Read More